Nucleus Software Exports Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: April 29, 2025, 1:33 pm

Market Cap	2,339 Cr.
Current Price	874
High / Low	1,645/724
Stock P/E	15.5
Book Value	268
Dividend Yield	1.43 %
ROCE	32.0 %
ROE	24.0 %
Face Value	10.0
PEG Ratio	2.32

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Nucleus Software Exports Ltd

Competitors of Nucleus Software Exports Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
IDream Film Infrastructure Company Ltd	1.79 Cr.	120	120/89.3		295	0.00 %	%	%	10.0
I Power Solutions India Ltd	7.42 Cr.	16.7	16.7/10.8		8.99	0.00 %	3.67 %	3.83 %	10.0
Hypersoft Technologies Ltd	8.64 Cr.	20.3	20.3/7.95		5.13	0.00 %	8.57 %	10.7 %	10.0
Sonata Software Ltd	10,496 Cr.	374	764/286	24.6	53.5	2.13 %	35.5 %	30.3 %	1.00
Softtech Engineers Ltd	497 Cr.	360	612/277	210	92.5	0.00 %	6.40 %	2.79 %	10.0
Industry Average	154,615.15 Cr	901.74		44.65	141.81	0.72%	20.57%	17.28%	7.00

All Competitor Stocks of Nucleus Software Exports Ltd

Quarterly Result

Metric	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Sales	122	153	129	130	169	206	207	205	204	210	195	202	206
Expenses	116	128	114	119	121	123	144	153	156	152	166	170	172
Operating Profit	6	25	15	11	48	83	63	52	48	58	29	32	33
OPM %	5%	16%	11%	9%	28%	40%	30%	25%	23%	28%	15%	16%	16%
Other Income	8	6	6	9	9	10	13	12	12	14	15	19	16
Interest	0	0	0	0	0	0	0	0	0	0	0	0	0
Depreciation	4	5	5	5	5	4	4	4	4	4	4	4	4
Profit before tax	9	26	16	15	52	89	72	60	56	68	40	47	45
Tax %	15%	30%	31%	26%	26%	24%	25%	26%	26%	24%	24%	29%	22%
Net Profit	8	18	11	11	38	68	54	45	41	52	30	33	35
EPS in Rs	2.77	6.83	4.02	4.12	14.32	25.27	20.01	16.65	15.43	19.47	11.28	12.35	13.06

Last Updated: February 28, 2025, 6:05 pm

Below is a detailed analysis of the quarterly data for Nucleus Software Exports Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

For Sales, as of Dec 2024, the value is 206.00 Cr.. The value appears strong and on an upward trend. It has increased from 202.00 Cr. (Sep 2024) to 206.00 Cr., marking an increase of 4.00 Cr..
For Expenses, as of Dec 2024, the value is 172.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 170.00 Cr. (Sep 2024) to 172.00 Cr., marking an increase of 2.00 Cr..
For Operating Profit, as of Dec 2024, the value is 33.00 Cr.. The value appears strong and on an upward trend. It has increased from 32.00 Cr. (Sep 2024) to 33.00 Cr., marking an increase of 1.00 Cr..
For OPM %, as of Dec 2024, the value is 16.00%. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 16.00%.
For Other Income, as of Dec 2024, the value is 16.00 Cr.. The value appears to be declining and may need further review. It has decreased from 19.00 Cr. (Sep 2024) to 16.00 Cr., marking a decrease of 3.00 Cr..
For Interest, as of Dec 2024, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 0.00 Cr..
For Depreciation, as of Dec 2024, the value is 4.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 4.00 Cr..
For Profit before tax, as of Dec 2024, the value is 45.00 Cr.. The value appears to be declining and may need further review. It has decreased from 47.00 Cr. (Sep 2024) to 45.00 Cr., marking a decrease of 2.00 Cr..
For Tax %, as of Dec 2024, the value is 22.00%. The value appears to be improving (decreasing) as expected. It has decreased from 29.00% (Sep 2024) to 22.00%, marking a decrease of 7.00%.
For Net Profit, as of Dec 2024, the value is 35.00 Cr.. The value appears strong and on an upward trend. It has increased from 33.00 Cr. (Sep 2024) to 35.00 Cr., marking an increase of 2.00 Cr..
For EPS in Rs, as of Dec 2024, the value is 13.06. The value appears strong and on an upward trend. It has increased from 12.35 (Sep 2024) to 13.06, marking an increase of 0.71.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 6, 2025, 3:20 pm

Metric	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Sales	294	346	353	349	372	412	484	521	514	497	634	826	814
Expenses	247	278	287	318	319	353	405	427	384	460	478	606	661
Operating Profit	46	68	66	31	54	59	79	94	129	37	157	220	152
OPM %	16%	20%	19%	9%	14%	14%	16%	18%	25%	7%	25%	27%	19%
Other Income	20	24	33	26	32	29	27	37	39	35	34	51	64
Interest	0	1	1	1	1	1	1	1	1	1	1	1	1
Depreciation	6	8	12	12	11	7	10	14	14	15	19	15	15
Profit before tax	60	83	87	44	74	80	96	117	154	56	171	256	200
Tax %	25%	23%	25%	26%	11%	22%	23%	24%	23%	26%	25%	25%
Net Profit	45	64	65	32	66	63	75	89	118	41	128	192	150
EPS in Rs	13.95	19.87	19.98	10.03	20.43	21.54	25.67	30.64	40.62	15.28	47.73	71.56	56.16
Dividend Payout %	22%	30%	25%	50%	24%	37%	35%	29%	22%	46%	21%	17%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2013-2014	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024
YoY Net Profit Growth (%)	42.22%	1.56%	-50.77%	106.25%	-4.55%	19.05%	18.67%	32.58%	-65.25%	212.20%	50.00%
Change in YoY Net Profit Growth (%)	0.00%	-40.66%	-52.33%	157.02%	-110.80%	23.59%	-0.38%	13.92%	-97.84%	277.45%	-162.20%

Nucleus Software Exports Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:	9%
5 Years:	11%
3 Years:	17%
TTM:	-1%

Compounded Profit Growth
10 Years:	11%
5 Years:	18%
3 Years:	18%
TTM:	-27%

Stock Price CAGR
10 Years:	16%
5 Years:	31%
3 Years:	27%
1 Year:	-37%

Return on Equity
10 Years:	15%
5 Years:	17%
3 Years:	17%
Last Year:	24%

Last Updated: Unknown

Balance Sheet

Last Updated: November 14, 2024, 7:57 pm

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	32	32	32	32	32	29	29	29	29	27	27	27	26
Reserves	318	365	406	425	503	432	480	532	643	467	584	751	690
Borrowings	0	0	0	1	0	0	0	6	6	2	6	5	3
Other Liabilities	109	116	118	123	131	184	177	196	206	241	257	332	428
Total Liabilities	459	513	556	581	665	645	685	763	885	737	874	1,114	1,147
Fixed Assets	51	61	58	54	48	48	47	57	50	59	50	59	57
CWIP	0	1	1	1	0	0	0	0	1	0	1	1	6
Investments	155	224	170	245	441	387	424	475	635	480	525	649	656
Other Assets	253	228	328	281	176	210	214	231	200	198	298	406	428
Total Assets	459	513	556	581	665	645	685	763	885	737	874	1,114	1,147

Below is a detailed analysis of the balance sheet data for Nucleus Software Exports Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

For Equity Capital, as of Sep 2024, the value is ₹26.00 Cr.. The value appears to be declining and may need further review. It has decreased from 27.00 Cr. (Mar 2024) to ₹26.00 Cr., marking a decrease of 1.00 Cr..
For Reserves, as of Sep 2024, the value is ₹690.00 Cr.. The value appears to be declining and may need further review. It has decreased from 751.00 Cr. (Mar 2024) to ₹690.00 Cr., marking a decrease of 61.00 Cr..
For Borrowings, as of Sep 2024, the value is ₹3.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 5.00 Cr. (Mar 2024) to ₹3.00 Cr., marking a decrease of 2.00 Cr..
For Other Liabilities, as of Sep 2024, the value is ₹428.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 332.00 Cr. (Mar 2024) to ₹428.00 Cr., marking an increase of 96.00 Cr..
For Total Liabilities, as of Sep 2024, the value is ₹1,147.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,114.00 Cr. (Mar 2024) to ₹1,147.00 Cr., marking an increase of 33.00 Cr..
For Fixed Assets, as of Sep 2024, the value is ₹57.00 Cr.. The value appears to be declining and may need further review. It has decreased from 59.00 Cr. (Mar 2024) to ₹57.00 Cr., marking a decrease of 2.00 Cr..
For CWIP, as of Sep 2024, the value is ₹6.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Mar 2024) to ₹6.00 Cr., marking an increase of 5.00 Cr..
For Investments, as of Sep 2024, the value is ₹656.00 Cr.. The value appears strong and on an upward trend. It has increased from 649.00 Cr. (Mar 2024) to ₹656.00 Cr., marking an increase of 7.00 Cr..
For Other Assets, as of Sep 2024, the value is ₹428.00 Cr.. The value appears strong and on an upward trend. It has increased from 406.00 Cr. (Mar 2024) to ₹428.00 Cr., marking an increase of 22.00 Cr..
For Total Assets, as of Sep 2024, the value is ₹1,147.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,114.00 Cr. (Mar 2024) to ₹1,147.00 Cr., marking an increase of 33.00 Cr..

Notably, the Reserves (690.00 Cr.) exceed the Borrowings (3.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Cash from Operating Activity +	74	66	37	33	95	77	56	75	115	58	50	222
Cash from Investing Activity +	-66	-56	-15	7	-78	61	-28	-28	-126	159	-12	-197
Cash from Financing Activity +	-9	-10	-23	-36	-1	-135	-26	-34	-13	-213	-23	-30
Net Cash Flow	-1	0	-1	4	16	3	2	12	-24	3	15	-5

Free Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Free Cash Flow	46.00	68.00	66.00	30.00	54.00	59.00	79.00	88.00	123.00	35.00	151.00	215.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	87	44	87	90	60	70	54	63	63	61	100	73
Inventory Days
Days Payable
Cash Conversion Cycle	87	44	87	90	60	70	54	63	63	61	100	73
Working Capital Days	19	-5	14	9	-43	-66	-51	-51	-58	-75	-14	-36
ROCE %	18%	21%	19%	10%	15%	16%	19%	21%	22%	6%	27%	32%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
Promoters	67.59%	73.28%	73.28%	73.27%	73.27%	73.27%	73.26%	73.27%	73.26%	73.26%	73.26%	73.59%
FIIs	3.74%	2.85%	2.87%	2.61%	2.63%	4.20%	3.99%	3.69%	5.02%	5.65%	5.35%	5.62%
DIIs	0.00%	0.00%	0.00%	0.16%	0.00%	0.33%	0.34%	0.59%	1.65%	1.90%	2.10%	1.75%
Public	28.67%	23.88%	23.85%	23.96%	24.10%	22.20%	22.40%	22.45%	20.05%	19.18%	19.28%	19.02%
No. of Shareholders	47,223	38,713	38,394	38,175	37,852	31,606	31,742	33,318	30,418	29,900	36,281	45,592

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund Name	No of Shares	AUM (%)	Amount Invested (Cr)	Previous Number of Shares	Previous Date	Percentage Change
WhiteOak Capital Flexi Cap Fund	113,333	0.63	16.66	113,333	2025-04-22 17:25:24	0%
ICICI Prudential Innovation Fund	65,999	0.3	9.7	65,999	2025-04-22 17:25:24	0%
WhiteOak Capital Mid Cap Fund	45,586	0.51	6.7	45,586	2025-04-22 17:25:24	0%
Quant Teck Fund	38,000	2.75	5.58	38,000	2025-04-22 17:25:24	0%
WhiteOak Capital Multi Cap Fund	25,166	0.71	3.7	25,166	2025-04-22 17:25:24	0%
WhiteOak Capital Large Cap Fund	11,472	0.46	1.69	11,472	2025-04-22 17:25:24	0%
WhiteOak Capital Balanced Advantage Fund	8,909	0.18	1.31	8,909	2025-04-22 17:25:24	0%
ICICI Prudential Technology Fund	6,651	0.01	0.98	6,651	2025-04-22 17:25:24	0%
WhiteOak Capital ELSS Tax Saver Fund	4,324	0.58	0.64	4,324	2025-04-22 17:25:24	0%
WhiteOak Capital Multi Asset Allocation Fund	1,716	0.1	0.25	1,716	2025-04-22 17:25:24	0%

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	71.56	47.73	14.28	40.62	30.64
Diluted EPS (Rs.)	71.56	47.73	14.28	40.62	30.64
Cash EPS (Rs.)	77.01	54.73	21.03	45.39	35.31
Book Value[Excl.RevalReserv]/Share (Rs.)	290.41	228.11	184.38	231.41	193.14
Book Value[Incl.RevalReserv]/Share (Rs.)	290.41	228.11	184.38	231.41	193.14
Revenue From Operations / Share (Rs.)	308.72	237.00	185.73	176.84	179.35
PBDIT / Share (Rs.)	101.34	71.28	26.78	58.16	45.27
PBIT / Share (Rs.)	95.91	64.29	21.03	53.38	40.60
PBT / Share (Rs.)	95.55	63.91	20.73	52.96	40.21
Net Profit / Share (Rs.)	71.57	47.74	15.28	40.62	30.64
NP After MI And SOA / Share (Rs.)	71.57	47.74	15.28	40.62	30.64
PBDIT Margin (%)	32.82	30.07	14.41	32.88	25.23
PBIT Margin (%)	31.06	27.12	11.32	30.18	22.63
PBT Margin (%)	30.95	26.96	11.16	29.95	22.42
Net Profit Margin (%)	23.18	20.14	8.22	22.96	17.08
NP After MI And SOA Margin (%)	23.18	20.14	8.22	22.96	17.08
Return on Networth / Equity (%)	24.64	20.92	8.28	17.55	15.86
Return on Capital Employeed (%)	31.36	26.84	10.84	22.57	20.53
Return On Assets (%)	17.19	14.61	5.55	13.33	11.66
Asset Turnover Ratio (%)	0.83	0.74	0.56	0.56	0.62
Current Ratio (X)	2.07	2.07	2.09	3.11	2.36
Quick Ratio (X)	2.07	2.07	2.09	3.11	2.36
Dividend Payout Ratio (NP) (%)	13.97	14.66	42.58	7.38	29.37
Dividend Payout Ratio (CP) (%)	12.98	12.79	30.94	6.60	25.49
Earning Retention Ratio (%)	86.03	85.34	57.42	92.62	70.63
Cash Earning Retention Ratio (%)	87.02	87.21	69.06	93.40	74.51
Interest Coverage Ratio (X)	285.58	187.09	88.51	138.44	117.37
Interest Coverage Ratio (Post Tax) (X)	202.68	126.28	51.51	97.68	80.46
Enterprise Value (Cr.)	3091.48	1658.15	1054.42	1353.67	425.81
EV / Net Operating Revenue (X)	3.74	2.61	2.12	2.64	0.81
EV / EBITDA (X)	11.40	8.69	14.71	8.01	3.24
MarketCap / Net Operating Revenue (X)	3.83	2.69	2.23	2.72	0.98
Retention Ratios (%)	86.02	85.33	57.41	92.61	70.62
Price / BV (X)	4.07	2.80	2.25	2.08	0.91
Price / Net Operating Revenue (X)	3.83	2.69	2.23	2.72	0.98
EarningsYield	0.06	0.07	0.03	0.08	0.17

After reviewing the key financial ratios for Nucleus Software Exports Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
For Basic EPS (Rs.), as of Mar 24, the value is 71.56. This value is within the healthy range. It has increased from 47.73 (Mar 23) to 71.56, marking an increase of 23.83.
For Diluted EPS (Rs.), as of Mar 24, the value is 71.56. This value is within the healthy range. It has increased from 47.73 (Mar 23) to 71.56, marking an increase of 23.83.
For Cash EPS (Rs.), as of Mar 24, the value is 77.01. This value is within the healthy range. It has increased from 54.73 (Mar 23) to 77.01, marking an increase of 22.28.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 290.41. It has increased from 228.11 (Mar 23) to 290.41, marking an increase of 62.30.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 290.41. It has increased from 228.11 (Mar 23) to 290.41, marking an increase of 62.30.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 308.72. It has increased from 237.00 (Mar 23) to 308.72, marking an increase of 71.72.
For PBDIT / Share (Rs.), as of Mar 24, the value is 101.34. This value is within the healthy range. It has increased from 71.28 (Mar 23) to 101.34, marking an increase of 30.06.
For PBIT / Share (Rs.), as of Mar 24, the value is 95.91. This value is within the healthy range. It has increased from 64.29 (Mar 23) to 95.91, marking an increase of 31.62.
For PBT / Share (Rs.), as of Mar 24, the value is 95.55. This value is within the healthy range. It has increased from 63.91 (Mar 23) to 95.55, marking an increase of 31.64.
For Net Profit / Share (Rs.), as of Mar 24, the value is 71.57. This value is within the healthy range. It has increased from 47.74 (Mar 23) to 71.57, marking an increase of 23.83.
For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 71.57. This value is within the healthy range. It has increased from 47.74 (Mar 23) to 71.57, marking an increase of 23.83.
For PBDIT Margin (%), as of Mar 24, the value is 32.82. This value is within the healthy range. It has increased from 30.07 (Mar 23) to 32.82, marking an increase of 2.75.
For PBIT Margin (%), as of Mar 24, the value is 31.06. This value exceeds the healthy maximum of 20. It has increased from 27.12 (Mar 23) to 31.06, marking an increase of 3.94.
For PBT Margin (%), as of Mar 24, the value is 30.95. This value is within the healthy range. It has increased from 26.96 (Mar 23) to 30.95, marking an increase of 3.99.
For Net Profit Margin (%), as of Mar 24, the value is 23.18. This value exceeds the healthy maximum of 10. It has increased from 20.14 (Mar 23) to 23.18, marking an increase of 3.04.
For NP After MI And SOA Margin (%), as of Mar 24, the value is 23.18. This value exceeds the healthy maximum of 20. It has increased from 20.14 (Mar 23) to 23.18, marking an increase of 3.04.
For Return on Networth / Equity (%), as of Mar 24, the value is 24.64. This value is within the healthy range. It has increased from 20.92 (Mar 23) to 24.64, marking an increase of 3.72.
For Return on Capital Employeed (%), as of Mar 24, the value is 31.36. This value is within the healthy range. It has increased from 26.84 (Mar 23) to 31.36, marking an increase of 4.52.
For Return On Assets (%), as of Mar 24, the value is 17.19. This value is within the healthy range. It has increased from 14.61 (Mar 23) to 17.19, marking an increase of 2.58.
For Asset Turnover Ratio (%), as of Mar 24, the value is 0.83. It has increased from 0.74 (Mar 23) to 0.83, marking an increase of 0.09.
For Current Ratio (X), as of Mar 24, the value is 2.07. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 2.07.
For Quick Ratio (X), as of Mar 24, the value is 2.07. This value exceeds the healthy maximum of 2. There is no change compared to the previous period (Mar 23) which recorded 2.07.
For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 13.97. This value is below the healthy minimum of 20. It has decreased from 14.66 (Mar 23) to 13.97, marking a decrease of 0.69.
For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 12.98. This value is below the healthy minimum of 20. It has increased from 12.79 (Mar 23) to 12.98, marking an increase of 0.19.
For Earning Retention Ratio (%), as of Mar 24, the value is 86.03. This value exceeds the healthy maximum of 70. It has increased from 85.34 (Mar 23) to 86.03, marking an increase of 0.69.
For Cash Earning Retention Ratio (%), as of Mar 24, the value is 87.02. This value exceeds the healthy maximum of 70. It has decreased from 87.21 (Mar 23) to 87.02, marking a decrease of 0.19.
For Interest Coverage Ratio (X), as of Mar 24, the value is 285.58. This value is within the healthy range. It has increased from 187.09 (Mar 23) to 285.58, marking an increase of 98.49.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 202.68. This value is within the healthy range. It has increased from 126.28 (Mar 23) to 202.68, marking an increase of 76.40.
For Enterprise Value (Cr.), as of Mar 24, the value is 3,091.48. It has increased from 1,658.15 (Mar 23) to 3,091.48, marking an increase of 1,433.33.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 3.74. This value exceeds the healthy maximum of 3. It has increased from 2.61 (Mar 23) to 3.74, marking an increase of 1.13.
For EV / EBITDA (X), as of Mar 24, the value is 11.40. This value is within the healthy range. It has increased from 8.69 (Mar 23) to 11.40, marking an increase of 2.71.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 3.83. This value exceeds the healthy maximum of 3. It has increased from 2.69 (Mar 23) to 3.83, marking an increase of 1.14.
For Retention Ratios (%), as of Mar 24, the value is 86.02. This value exceeds the healthy maximum of 70. It has increased from 85.33 (Mar 23) to 86.02, marking an increase of 0.69.
For Price / BV (X), as of Mar 24, the value is 4.07. This value exceeds the healthy maximum of 3. It has increased from 2.80 (Mar 23) to 4.07, marking an increase of 1.27.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 3.83. This value exceeds the healthy maximum of 3. It has increased from 2.69 (Mar 23) to 3.83, marking an increase of 1.14.
For EarningsYield, as of Mar 24, the value is 0.06. This value is below the healthy minimum of 5. It has decreased from 0.07 (Mar 23) to 0.06, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Nucleus Software Exports Ltd as of April 30, 2025 is: 808.97

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of April 30, 2025, Nucleus Software Exports Ltd is Overvalued by 7.44% compared to the current share price 874.00

Intrinsic Value of Nucleus Software Exports Ltd as of April 30, 2025 is: 863.12

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of April 30, 2025, Nucleus Software Exports Ltd is Overvalued by 1.24% compared to the current share price 874.00

Last 5 Year EPS CAGR: 6.69%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a high average ROCE of 18.83%, which is a positive sign. The stock has a low average Working Capital Days of -29.75, which is a positive sign. The company has higher reserves (507.38 cr) compared to borrowings (2.23 cr), indicating strong financial stability. The company has shown consistent growth in sales (493.54 cr) and profit (113.69 cr) over the years.	The stock has a high average Cash Conversion Cycle of 71.00, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Nucleus Software Exports Ltd:
1. Net Profit Margin: 23.18%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 31.36% (Industry Average ROCE: 20.57%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 24.64% (Industry Average ROE: 17.28%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 202.68
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 2.07
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 15.5 (Industry average Stock P/E: 44.65)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Nucleus Software Exports Ltd. is a Public Limited Listed company incorporated on 09/01/1989 and has its registered office in the State of Delhi, India. Company's Corporate Identification Number(CIN) is L74899DL1989PLC034594 and registration number is 034594. Currently Company is involved in the business activities of Computer programming, consultancy and related activities. Company's Total Operating Revenue is Rs. 766.12 Cr. and Equity Capital is Rs. 26.77 Cr. for the Year ended 31/03/2024.

INDUSTRY	ADDRESS	CONTACT
IT Consulting & Software	33-35, Thyagraj Nagar Market, New Delhi Delhi 110003	investorrelations@nucleussoftware.com http://www.nucleussoftware.com

Management
Name	Position Held
Mr. S M Acharya	Chairman(NonExe.&Ind.Director)
Mr. Vishnu R Dusad	Managing Director
Mr. Anurag Mantri	Executive Director & CFO
Mr. Parag Bhise	Executive Director & CEO
Mr. Ravi Pratap Singh	Executive Director
Dr. Ritika Dusad	Executive Director
Mr. Prithvi Haldea	Ind. Non-Executive Director
Mrs. Elaine Mathias	Ind. Non-Executive Director
Prof. Trilochan Sastry	Ind. Non-Executive Director
Ms. Yasmin Javeri Krishan	Ind. Non-Executive Director
Mr. P C Kandpal	Ind. Non-Executive Director
Mr. Shekar Viswanathan	Ind. Non-Executive Director

FAQ

What is the intrinsic value of Nucleus Software Exports Ltd?

Nucleus Software Exports Ltd's intrinsic value (as of 29 April 2025) is ₹808.97 — 7.44% lower the current market price of 874.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 2,339 Cr. market cap, FY2025-2026 high/low of ₹1,645/724, reserves of 690 Cr, and liabilities of 1,147 Cr.

What is the Market Cap of Nucleus Software Exports Ltd?

The Market Cap of Nucleus Software Exports Ltd is 2,339 Cr..

What is the current Stock Price of Nucleus Software Exports Ltd as on 29 April 2025?

The current stock price of Nucleus Software Exports Ltd as on 29 April 2025 is 874.

What is the High / Low of Nucleus Software Exports Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Nucleus Software Exports Ltd stocks is ₹1,645/724.

What is the Stock P/E of Nucleus Software Exports Ltd?

The Stock P/E of Nucleus Software Exports Ltd is 15.5.

What is the Book Value of Nucleus Software Exports Ltd?

The Book Value of Nucleus Software Exports Ltd is 268.

What is the Dividend Yield of Nucleus Software Exports Ltd?

The Dividend Yield of Nucleus Software Exports Ltd is 1.43 %.

What is the ROCE of Nucleus Software Exports Ltd?

The ROCE of Nucleus Software Exports Ltd is 32.0 %.

What is the ROE of Nucleus Software Exports Ltd?

The ROE of Nucleus Software Exports Ltd is 24.0 %.

What is the Face Value of Nucleus Software Exports Ltd?

The Face Value of Nucleus Software Exports Ltd is 10.0.